National estimates of cancer prevalence in China, 2011

Cancer Letters

Volumn 370, Issue 1, 2016, Pages 33-38

  Zheng, Rongshou ^a   Zeng, Hongmei ^a   Zhang, Siwei ^a   Chen, Tianhui ^b,c   Chen, Wanqing ^a  

^a National Cancer Center   (China)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Cancer burden; China; Epidemiology; Health care services; Prevalence

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLADDER CANCER; BONE CANCER; BRAIN CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER SURVIVAL; CANCER SURVIVOR; CHINA; COLORECTAL CANCER; CONTROLLED STUDY; CUTANEOUS MELANOMA; ESOPHAGUS CANCER; FEMALE; GALLBLADDER CANCER; HUMAN; KIDNEY CANCER; LARYNX CANCER; LEUKEMIA; LIP CANCER; LIVER CANCER; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; NASOPHARYNX CANCER; NEOPLASM; OVARY CANCER; PANCREAS CANCER; PHARYNX CANCER; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; SEX DIFFERENCE; SEX RATIO; STOMACH CANCER; TESTIS CANCER; THYROID CANCER; URBAN RURAL DIFFERENCE; UTERINE CERVIX CANCER; UTERUS CANCER; MIDDLE AGED; MORTALITY; NEOPLASMS; REGISTER; TIME FACTOR;

ADULT; AGED; CHINA; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; REGISTRIES; TIME FACTORS;

EID: 84949481070     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.10.003     Document Type: Article

References (28)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 2001, 94:153-156.
2. Micheli A., Mugno E., Krogh V., Quinn M.J., Coleman M., Hakulinen T., et al. Cancer prevalence in European registry areas. Ann. Oncol 2002, 13:840-865.
3. Bray F., Ren J.S., Masuyer E., Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in. Int. J. Cancer 2008, 132(2013):1133-1145.
4. Zhang S.-W., Cheng W., Wang L. The 30 years of cancer registration in China. China Cancer 2009, 18:256-259.
5. Crocetti E., De Angelis R., Buzzoni C., Mariotto A., Storm H., Colonna M., et al. Cancer prevalence in United States, Nordic Countries, Italy, Australia, and France: an analysis of geographic variability. Br. J. Cancer 2013, 109:219-228.
6. Gatta G., Mallone S., van der Zwan J.M., Trama A., Siesling S., Capocaccia R., et al. Cancer prevalence estimates in Europe at the beginning of 2000. Ann. Oncol 2013, 24:1660-1666.
7. Maddams J., Utley M., Moller H. Projections of cancer prevalence in the United Kingdom, 2010-2040. Br. J. Cancer 2012, 107:1195-1202.
8. Yu X.Q., Clements M., O'Connell D. Projections of cancer prevalence by phase of care: a potential tool for planning future health service needs. J. Cancer Surviv 2013, 7:641-651.
9. International Agency for Research on Cancer, GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012.
10. Giles G. How important are estimates of cancer prevalence?. Ann. Oncol 2002, 13:815-816.
11. Chen W., Zheng R., Zeng H., Zhang S., He J. Annual report on status of cancer in China, 2011. Chin. J. Cancer Res 2015, 27:2-12.
12. Ferlay J., Burkhard C., Whelan S., Parkin D. Check and conversion programs for cancer registries (IARC/IACR tools for cancer registries) 2005, International Agency for Research on Cancer, Lyon.
13. Chen V., Ferlay J., Padrós J.G., Storm H., Whelan S., Parkin D., et al. Comparability and Quality Control in Cancer Registration 1994, IARC.
14. Curado M.-P., Edwards B., Shin H.R., Storm H., Ferlay J., Heanue M., et al. Cancer Incidence in Five Continents 2007, vol. IX. IARC Press, International Agency for Research on Cancer.
15. Bray F., Parkin D.M. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. Eur. J. Cancer 2009, 45:747-755.
16. Parkin D.M., Bray F. Evaluation of data quality in the cancer registry: principles and methods. Part II. Completeness. Eur. J. Cancer 2009, 45:756-764.
17. Zeng H., Zheng R., Guo Y., Zhang S., Zou X., Wang N., et al. Cancer survival in China, 2003-2005: a population-based study. Int. J. Cancer 2015, 136(8):1921-1930.
18. World Health Organization ICD 10: International Statistical Classification of Diseases and Related Health Problems 1992, vol. 1.
19. Pisani P., Bray F., Parkin D.M. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int. J. Cancer 2002, 97:72-81.
20. Miller R.G. Survival Analysis 2011, John Wiley & Sons.
21. Allison P.D. Survival Analysis Using SAS: A Practical Guide 2010, SAS Institute.
22. Colonna M., Mitton N., Bossard N., Belot A., Grosclaude P. Total and partial cancer prevalence in the adult French population in 2008. BMC Cancer 2015, 15:153. French Network of Cancer Registries (FRANCIM).
23. Maxwell S., O'Leary P., Slevin T., Moorin R. The increase in cancer prevalence and hospital burden in Western Australia, 1992-2011. Popul. Health Metr 2014, 12:33.
24. Bernard D.S.M., Farr S.L., Fang Z.Y. National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008. J. Clin. Oncol 2011, 29:2821-2826.
25. Chen W.Q., Zeng H.M., Zheng R.S., Zhang S.W., He J. Cancer incidence and mortality in china, 2007. Chin. J. Cancer Res 2012, 24:1-8.
26. Chen W.Q., Zheng R.S., Zhang S.W., Li N., Zhao P., Li G.L., et al. Report of incidence and mortality in china cancer registries, 2008. Chin. J. Cancer Res 2012, 24:171-180.
27. Chen W., Zheng R., Zhang S., Zhao P., Li G., Wu L., et al. Report of incidence and mortality in China cancer registries, 2009. Chin. J. Cancer Res 2013, 25:10-21.
28. Chen W., Zheng R., Zhang S., Zhao P., Zeng H., Zou X., et al. Annual report on status of cancer in China, 2010. Chin. J. Cancer Res 2014, 26:48-58.